adesso Croissance future
Future contrôle des critères 4/6
adesso devrait augmenter ses bénéfices et son chiffre d'affaires de 42.3% et de 11.5% par an respectivement. Le BPA devrait croître de de 41% par an. Le rendement des capitaux propres devrait être 12.9% dans 3 ans.
Informations clés
42.3%
Taux de croissance des bénéfices
41.0%
Taux de croissance du BPA
| IT croissance des bénéfices | 15.0% |
| Taux de croissance des recettes | 11.5% |
| Rendement futur des capitaux propres | 12.9% |
| Couverture par les analystes | Good |
| Dernière mise à jour | 20 Nov 2024 |
Mises à jour récentes de la croissance future
adesso SE (ETR:ADN1) Just Reported, And Analysts Assigned A €122 Price Target
Nov 17
Analysts Are Updating Their adesso SE (ETR:ADN1) Estimates After Its Annual Results
Mar 28Recent updates
adesso (ETR:ADN1) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Nov 22adesso SE (ETR:ADN1) Just Reported, And Analysts Assigned A €122 Price Target
Nov 17Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?
Nov 02It's Down 25% But adesso SE (ETR:ADN1) Could Be Riskier Than It Looks
Aug 28adesso's (ETR:ADN1) Shareholders Will Receive A Bigger Dividend Than Last Year
May 21adesso (ETR:ADN1) Has Announced That It Will Be Increasing Its Dividend To €0.70
Apr 19Returns On Capital Signal Tricky Times Ahead For adesso (ETR:ADN1)
Apr 18Investors Can Find Comfort In adesso's (ETR:ADN1) Earnings Quality
Apr 02Analysts Are Updating Their adesso SE (ETR:ADN1) Estimates After Its Annual Results
Mar 28Is adesso SE (ETR:ADN1) Trading At A 44% Discount?
Mar 23adesso SE (ETR:ADN1) Soars 29% But It's A Story Of Risk Vs Reward
Mar 08A Look At The Intrinsic Value Of adesso SE (ETR:ADN1)
Dec 14Does adesso (ETR:ADN1) Have A Healthy Balance Sheet?
Oct 11At €106, Is It Time To Put adesso SE (ETR:ADN1) On Your Watch List?
Jul 22Calculating The Intrinsic Value Of adesso SE (ETR:ADN1)
Jun 15adesso's (ETR:ADN1) Returns On Capital Not Reflecting Well On The Business
May 09What Does adesso SE's (ETR:ADN1) Share Price Indicate?
Apr 22adesso (ETR:ADN1) Has A Pretty Healthy Balance Sheet
Feb 11Returns On Capital At adesso (ETR:ADN1) Have Stalled
Jan 26Calculating The Fair Value Of adesso SE (ETR:ADN1)
Jan 10At €138, Is It Time To Put adesso SE (ETR:ADN1) On Your Watch List?
Dec 14We Think adesso (ETR:ADN1) Can Stay On Top Of Its Debt
Aug 22Why adesso SE (ETR:ADN1) Could Be Worth Watching
Aug 07adesso (ETR:ADN1) Hasn't Managed To Accelerate Its Returns
Jul 21Is adesso (ETR:ADN1) A Risky Investment?
May 12Is It Too Late To Consider Buying adesso SE (ETR:ADN1)?
Apr 29adesso (ETR:ADN1) Might Be Having Difficulty Using Its Capital Effectively
Apr 12Should You Be Adding adesso (ETR:ADN1) To Your Watchlist Today?
Mar 29Is There Now An Opportunity In adesso SE (ETR:ADN1)?
Jan 13I Ran A Stock Scan For Earnings Growth And adesso (ETR:ADN1) Passed With Ease
Dec 27adesso (ETR:ADN1) Has A Pretty Healthy Balance Sheet
Oct 16Why adesso SE (ETR:ADN1) Could Be Worth Watching
Sep 28Do adesso's (ETR:ADN1) Earnings Warrant Your Attention?
Aug 23Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2026 | 1,639 | 39 | 61 | 95 | 6 |
| 12/31/2025 | 1,468 | 27 | 43 | 79 | 6 |
| 12/31/2024 | 1,304 | 12 | 16 | 55 | 6 |
| 9/30/2024 | 1,269 | 5 | 102 | 135 | N/A |
| 6/30/2024 | 1,225 | -1 | 94 | 129 | N/A |
| 3/31/2024 | 1,182 | -2 | 51 | 83 | N/A |
| 12/31/2023 | 1,140 | 3 | 43 | 77 | N/A |
| 9/30/2023 | 1,084 | 5 | -23 | 7 | N/A |
| 6/30/2023 | 1,037 | 12 | -28 | -1 | N/A |
| 3/31/2023 | 969 | 18 | 7 | 35 | N/A |
| 12/31/2022 | 901 | 29 | 12 | 36 | N/A |
| 9/30/2022 | 836 | 29 | 12 | 36 | N/A |
| 6/30/2022 | 769 | 28 | 12 | 33 | N/A |
| 3/31/2022 | 725 | 37 | 17 | 36 | N/A |
| 12/31/2021 | 678 | 48 | 30 | 48 | N/A |
| 9/30/2021 | 636 | 45 | 23 | 43 | N/A |
| 6/30/2021 | 600 | 46 | 23 | 37 | N/A |
| 3/31/2021 | 564 | 42 | 34 | 47 | N/A |
| 12/31/2020 | 524 | 21 | 54 | 65 | N/A |
| 9/30/2020 | 503 | 24 | 34 | 40 | N/A |
| 6/30/2020 | 484 | 19 | 34 | 43 | N/A |
| 3/31/2020 | 467 | 18 | 22 | 33 | N/A |
| 12/31/2019 | 451 | 17 | 11 | 22 | N/A |
| 9/30/2019 | 432 | 15 | 1 | 13 | N/A |
| 6/30/2019 | 412 | 13 | -9 | 3 | N/A |
| 3/31/2019 | 395 | 13 | 0 | 10 | N/A |
| 12/31/2018 | 378 | 14 | 9 | 18 | N/A |
| 9/30/2018 | 364 | 14 | 14 | 22 | N/A |
| 6/30/2018 | 351 | 14 | N/A | 26 | N/A |
| 3/31/2018 | 336 | 13 | N/A | 23 | N/A |
| 12/31/2017 | 322 | 11 | N/A | 20 | N/A |
| 9/30/2017 | 307 | 11 | N/A | 17 | N/A |
| 6/30/2017 | 292 | 11 | N/A | 13 | N/A |
| 3/31/2017 | 276 | 12 | N/A | 14 | N/A |
| 12/31/2016 | 261 | 12 | N/A | 15 | N/A |
| 9/30/2016 | 245 | 10 | N/A | 14 | N/A |
| 6/30/2016 | 229 | 7 | N/A | 14 | N/A |
| 3/31/2016 | 213 | 6 | N/A | 15 | N/A |
| 12/31/2015 | 197 | 5 | N/A | 17 | N/A |
| 9/30/2015 | 183 | 4 | N/A | 17 | N/A |
| 6/30/2015 | 169 | 4 | N/A | 16 | N/A |
| 3/31/2015 | 163 | 4 | N/A | 13 | N/A |
| 12/31/2014 | 157 | 3 | N/A | 9 | N/A |
| 9/30/2014 | 151 | 3 | N/A | 7 | N/A |
| 6/30/2014 | 145 | 2 | N/A | 5 | N/A |
| 3/31/2014 | 140 | 3 | N/A | 7 | N/A |
| 12/31/2013 | 135 | 3 | N/A | 8 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de ADN1 ( 42.3% par an) est supérieure au taux d'épargne ( 1% ).
Bénéfices vs marché: Les bénéfices de ADN1 ( 42.3% par an) devraient croître plus rapidement que le marché German ( 21.1% par an).
Croissance élevée des bénéfices: Les bénéfices de ADN1 devraient augmenter de manière significative au cours des 3 prochaines années.
Chiffre d'affaires vs marché: Le chiffre d'affaires de ADN1 ( 11.5% par an) devrait croître plus rapidement que le marché German ( 5.7% par an).
Croissance élevée des revenus: Le chiffre d'affaires de ADN1 ( 11.5% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de ADN1 devrait être faible dans 3 ans ( 12.9 %).